AARA News
Proud Sponsors of the Arthritis Foundation – Walk to Cure Arthritis
AARA proudly participated in this year’s Walk to Cure Arthritis, joining the community in raising awareness and support for those living with arthritis. Our team of providers, staff, patients, and families walked together in solidarity and celebration of progress in arthritis care. The event raised a grand total of $172,064 to support vital services and scientific research. We’re honored to have been part of such an inspiring event!
Found Hiding in Plain Sight
How an Innovative Healthcare Partnership Facilitated Earlier Identification of Patients at Risk for Axial Spondyloarthritis (axSpA)
In partnership with UCB and NextGen Healthcare, our team provided clinical direction and rheumatology expertise to facilitate earlier identification of patients at risk for axial spondyloarthritis (axSpA).
Learn more about this unprecedented partnership that delivered impact here >
Switching from Adalimumab Reference Product to and Among Adalimumab Biosimilars Outside the USA: Insights for US Clinicians
A new review article led by Dr. John R. P. Tesser, MD, FACP, FACR, MACR, and AARA Clinical Research offers key insights for U.S. clinicians on switching from reference product adalimumab to its biosimilars based on data from outside the U.S. The review finds that switching to adalimumab biosimilars is generally safe and effective across multiple chronic inflammatory diseases. While most patients maintain stable outcomes after switching, the study highlights the importance of patient education, physician guidance, and supportive policies. The findings support broader use of biosimilars to reduce costs and expand access to care in the U.S. healthcare system.
Read the full review article here:
https://link.springer.com/article/10.1007/s40259-025-00719-z
AARA Hits the Hill!
Pictured from left to right: AARA Executive Leadership members Dr. Andrew Sharobeem, CEO Angel Magar, and Dr. Nehad Soloman stand in front of Capitol Hill.
We are proud to stand with the American College of Rheumatology on Capitol Hill—advocating for our patients, supporting fellow rheumatologists in delivering exceptional care, opposing Medicaid cuts, demanding meaningful Pharmacy Benefit Manager reform, and fighting for better resources for our veterans. We’re here for Arizona—and for patients across the nation!
Andrew Sharobeem, DO, FACR
